Epidemiological Characteristics of Breast Cancer in the Voronezh Region in 2015–2019

Summary

Introduction: Breast cancer is the most commonly occurring cancer in women worldwide. Incidence rates are continuously growing globally. In the Russian Federation, women with breast cancer make up the largest proportion of all cancer cases.

Objective: To analyze breast cancer statistics in the Voronezh Region for 2015–2019.

Materials and methods: We used data of the Statistical Reporting Form No. 7, Information about Malignant Neoplasms, for 2015–2019 and the statistical bulletin on Age and Sex Distribution of the Population of the Voronezh Region. Women living in the Voronezh Region and first diagnosed with breast cancer in 2015–2019 were included in the analysis. Statistical parameters were calculated using the Microsoft Office Excel 2016 software; the p-value of 0.05 or lower was considered statistically   significant.

Results: Breast cancer rates in the Voronezh Region in 2015–2019 had a moderate upward trend: incidence rates rose from 85.91 in 2015 to 93.89 in 2019 while prevalence rates grew from 904.5 to 1,001.1 per 100,000 female population. The mortality from breast cancer, however, demonstrated a pronounced downward trend dropping from 37.69 to 24.23 per 100,000 female population over the same period. The risk of breast cancer in women rose significantly with age (r = 0.65, p < 0.001) and the highest incidence rates were registered in the age group of 60 to 74 years. Most incident cases were diagnosed with stage II breast cancer. Yet, the proportion of new cases with stage I breast cancer grew statistically from 21.9 to 30.2 % (p < 0.0001) in 2015–2019. The accounting information reliability index for the malignancy decreased from 0.4 to 0.2.

Conclusions: Breast cancer incidence and prevalence rates among the female population of the Voronezh Region showed a moderate upward trend in 2015–2019. A pronounced trend towards a decrease in mortality rates, a significant increase in the number of incident cases diagnosed with stage I of the neoplasm, and a decrease in the accounting reliability index reflect qualitative changes in the system of cancer care and improvements in cancer registration in the region.

1. Kaprin AD, Starinsky VV, Shakhzadova AO, eds. [Cancer Treatment in Russia in 2021.] Moscow: MNIOI im. P.A. Herzen – Branch NMITs Radiology Publ.; 2022. (In Russ.)

2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi: 10.3322/caac.21660

3. Aksel EM, Vinogradova NN. Statistics of malignant neoplasms of female reproductive organs. Onkoginekologiya. 2018;(3(27)):64-78. (In Russ.) doi: 10.52313/22278710_2018_3_64

4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394424. doi: 10.3322/caac.21492

5. Ginsburg O, Bray F, Coleman MP, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847–860. doi: 10.1016/S0140-6736(16)31392-7

6. Liu FC, Lin HT, Kuo CF, See LC, Chiou MJ, Yu HP. Epidemiology and survival outcome of breast cancer in a nationwide study. Oncotarget. 2017;8(10):16939-16950. doi: 10.18632/oncotarget.15207

7. Rezaianzadeh A, Jalali M, Maghsoudi A, Mokhtari AM, Azgomi SH, Dehghani SL. The overall 5-year survival rate of breast cancer among Iranian women: A systematic review and meta-analysis of published studies. Breast Dis. 2017;37(2):63-68. doi: 10.3233/BD-160244

8. Ogiya R, Niikura N, Kumamaru H, et al. Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study. Breast Cancer Res Treat. 2020;184(2):585-596. doi: 10.1007/s10549-020-05869-y

9. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-1953. doi: 10.1002/ijc.31937

10. Escala-Garcia M, Morra A, Canisius S, et al. Breast cancer risk factors and their effects on survival: a Mendelian randomisation study. BMC Med. 2020;18(1):327. doi: 10.1186/s12916-020-01797-2

11. Kashyap D, Pal D, Sharma R, et al. Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int. 2022;2022:9605439. doi: 10.1155/2022/9605439

12. de Boer MC, Wörner EA, Verlaan D, van Leeuwen PAM. The mechanisms and effects of physical activity on breast cancer. Clin Breast Cancer. 2017;17(4):272-278. doi: 10.1016/j.clbc.2017.01.006

13. Ramírez K, Acevedo F, Herrera ME, Ibáñez C, Sánchez C. [Physical activity and breast cancer.] Rev Med Chil. 2017;145(1):75-84. (In Span.) doi: 10.4067/S003498872017000100011

14. Gatueva FS, Lyubchenko LN, Malygin SE. Hereditary breast cancer: Present status of problem. Klinicheskaya Praktika. 2020;11(1):103-111. (In Russ.) doi: 10.17816/clinpract18964

15. Kuusisto KM, Bebel A, Vihinen M, Schleutker J, Sallinen SL. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50 and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Breast Cancer Res. 2011;13(1):R20. doi: 10.1186/bcr2832

16. Siddig A, Tengku Din TADA, Mohd Nafi SN, Yahya MM, Sulong S, Wan Abdul Rahman WF. The unique biology behind the early onset of breast cancer. Genes (Basel). 2021;12(3):372. doi: 10.3390/genes12030372

17. Criscitiello C, Corti C. Breast cancer genetics: diagnostics and treatment. Genes (Basel). 2022;13(9):1593. doi: 10.3390/genes13091593

18. Fernández MF, Reina-Pérez I, Astorga JM, Rodríguez-Carrillo A, Plaza-Díaz J, Fontana L. Breast cancer and its relationship with the microbiota. Int J Environ Res Public Health. 2018;15(8):1747. doi: 10.3390/ijerph15081747

19. Eliassen AH, Liao X, Rosner B, Tamimi RM, Tworoger SS, Hankinson SE. Plasma carotenoids and risk of breast cancer over 20 y of follow-up. Am J Clin Nutr. 2015;101(6):1197– 1205. doi: 10.3945/ajcn.114.105080

20. Huss L, Butt ST, Borgquist S, et al. Vitamin D receptor expression in invasive breast tumors and breast cancer survival. Breast Cancer Res. 2019;21(1):84. doi: 10.1186/s13058-019-1169-1

21. Merabishvili VM. Priority tasks of improving cancer registry in Russia. Biosfera. 2018;10(2):176-204. (In Russ.) doi: 10.24855/BIOSFERA.V10I2.443

22. Arnold M, Morgan E, Rumgay H, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15-23. doi: 10.1016/j.breast.2022.08.010